Physical Activity Intervention Effects on Executive Function, Physical Activity and Sedentary Behaviour in Children
NCT06376864, Not applicable, Completed, Hong Kong Baptist University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Physical Activity Intervention Effects on Executive Function, Physical Activity and Sedentary Behaviour in Children | ClinicalTrials.gov |
| NCT number | NCT06376864 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 450 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Hong Kong Baptist University | ClinicalTrials.gov |
| Conditions | Child Behavior | ClinicalTrials.gov |
| Interventions | Activity Breaks | ClinicalTrials.gov |
| First posted | 2024-04-19 | ClinicalTrials.gov |
| Last updated | 2024-10-18 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Executive function | baseline, 8 weeks, and 20 weeks | The Wisconsin Card Sorting Test (WCST): The computerized version of the WCST will be used to assess flexibility in decision making in this study. The number of total errors and perseverative errors and failure to maintain a set will be used as scores. | ClinicalTrials.gov |
| Primary | Psychological capacities | baseline, 8 weeks, and 20 weeks | Stroop Task. A computerized modified Stroop task will be used to reflect inhibition skills that help individuals override a prepotent response in favour of an alternative response. | ClinicalTrials.gov |
| Primary | Working memory | baseline, 8 weeks, and 20 weeks | Digit Span Backward: In this test, a participant will be presented with a series of digits to be repeated backwards. | ClinicalTrials.gov |
| Primary | Attention | baseline, 8 weeks, and 20 weeks | Measures of child attention levels will be measured using the online version of d2-R test of attention. TN-E is a total performance score which gives a measure of the relationship between performance accuracy and speed. TN-E scores are defined as 50-60% bad, 60-70% medium, 70-85% normal and over 85% is good. | ClinicalTrials.gov |
| Secondary | Physical activity (min/week) | baseline, 8 weeks, and 20 weeks | The ActiGraph GT3X+ monitor (ActiGraph LLC, Pensacola, FL, USA) will be used to measure physical activity levels. | ClinicalTrials.gov |
| Secondary | Sedentary behavior (hour) | baseline, 8 weeks, and 20 weeks | The ActiGraph GT3X+ monitor (ActiGraph LLC, Pensacola, FL, USA) will be used to measure sedentary behavior. | ClinicalTrials.gov |
| Secondary | Body weight (kg) | baseline, 8 weeks, and 20 weeks | Body weight will be measured in light clothing to the nearest 0.1 kg with a calibrated electronic scale. | ClinicalTrials.gov |
| Secondary | Height (cm) | baseline, 8 weeks, and 20 weeks | Height will be measured without shoes to the nearest 0.1 cm using a stadiometer in accordance with standard procedures. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 34
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 10797032 | BACKGROUND | PubMed |
| 14580627 | BACKGROUND | PubMed |
| 15147597 | BACKGROUND | PubMed |
| 15724566 | BACKGROUND | PubMed |
| 17146314 | BACKGROUND | PubMed |
| 17466077 | BACKGROUND | PubMed |
| 21143901 | BACKGROUND | PubMed |
| 21245072 | BACKGROUND | PubMed |
| 21281672 | BACKGROUND | PubMed |
| 21936895 | BACKGROUND | PubMed |
| 21970511 | BACKGROUND | PubMed |
| 22267291 | BACKGROUND | PubMed |
| 22974754 | BACKGROUND | PubMed |
| 23504941 | BACKGROUND | PubMed |
| 23707474 | BACKGROUND | PubMed |
| 23819701 | BACKGROUND | PubMed |
| 25426906 | BACKGROUND | PubMed |
| 25459234 | BACKGROUND | PubMed |
| 26197943 | BACKGROUND | PubMed |
| 26297105 | BACKGROUND | PubMed |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Primary outcome | ConductCognition |
| Digit Span Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.3.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
Release trials-2026-11-12-0.3.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.